This drives abnormal aggregation of TCA cycle-related proteins and cuproptosis, underscoring the central role of cuproptosis in IDD progression and proposing the SP1/FDX1 pathway as a novel therapeutic target. Here, SP1 is linked to intervertebral disk degenerative disorder.